YARROW BIOSCIENCE, INC. Deferred Tax Assets, Operating Loss Carryforwards
YARROW BIOSCIENCE, INC. (YARW) had Deferred Tax Assets, Operating Loss Carryforwards of $76.43 million as of 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-03
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $76.43M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $75.92M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $72.51M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $72.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $76.43M S-4/A · filed 2026-06-03 | |
| 2024-12-31 | $75.92M S-4/A · filed 2026-06-03 | |
| 2023-12-31 | $72.51M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $72.90M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $73.26M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $55.51M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $59.24M 10-K · filed 2021-03-04 | $35.97M 10-K · filed 2020-03-03 |
| 2018-12-31 | $22.25M 10-K · filed 2020-03-03 | |
| 2017-12-31 | $10.40M 10-K · filed 2020-03-03 | |
| 2016-12-31 | $10.46M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $5.99M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |